Alembic Ltd

Alembic Ltd Share Price Today: Live Updates & Key Insights

Get insights on Alembic Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.

Alembic Ltd Share Price Chart

Alembic Ltd Fundamentals

Traded Volume: 2,19,086

Market Cap(Cr): 2,558

Avg Traded Price 45.95

1 Year return -27.10%

Upper Circuit 99.9

Lower Circuit 98.1

P/E TTM 8.00

P/B Ratio 12.00

Traded Value(Cr) 218.23

EPS TTM 12.326

Book value 12.326

Dividend 2.00%

Alembic Ltd Share Price Performance

Shows the percentage change in stock price over different time periods

This section highlights Alembic Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Alembic Ltd share price history, short-term movements, long-term trends, and overall investor sentiment

1W -0.81%

1M -2.48%

3M -8.62%

1Y -27.10%

YTD -24.67%

Alembic Ltd Traded Volume Movement

Shows the trading volume over different time periods

This section highlights Alembic Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment

Yesterday 2.44L

Day Before Yesterday 4.07L

1W Avg 2.98L

1M Avg 2.76L

3M Avg 2.64L

Alembic Ltd Technical Details

Alembic Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.

Support 1 98

Support 2 97

Support 3 97

Pivot Point : 99

Resistance 1 100

Resistance 2 101

Resistance 3 102

Alembic Ltd Corporate Actions

Alembic Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Alembic Ltd’s capital allocation strategies.

All

Ex-Date 05-Aug-2025 Type D Description 2.40/share@120.00% Record Date 05-Aug-2025 Ratio 120.00

Ex-Date 05-Aug-2024 Type D Description 2.40/share@120.00% Record Date 05-Aug-2024 Ratio 120.00

Ex-Date 03-Aug-2023 Type D Description 2.20/share@110.00% Record Date 03-Aug-2023 Ratio 110.00

Ex-Date 12-Sep-2022 Type D Description 1.80/share@90.00% Record Date 13-Sep-2022 Ratio 90.00

Ex-Date 29-Jul-2021 Type D Description 0.20/share@10.00% Record Date 07-Nov-2025 Ratio 10.00

Ex-Date 29-Jul-2020 Type D Description 0.60/share@30.00% Record Date 07-Nov-2025 Ratio 30.00

Ex-Date 18-Sep-2019 Type D Description 0.20/share@10.00% Record Date 07-Nov-2025 Ratio 10.00

Ex-Date 27-Jul-2018 Type D Description 0.20/share@10.00% Record Date 07-Nov-2025 Ratio 10.00

Ex-Date 22-Mar-2018 Type T Description /share@% Record Date 07-Nov-2025 Ratio

Ex-Date 19-Jul-2017 Type D Description 0.20/share@10.00% Record Date 07-Nov-2025 Ratio 10.00

Ex-Date 01-Aug-2016 Type D Description 0.15/share@7.50% Record Date 07-Nov-2025 Ratio 7.50

Ex-Date 03-Aug-2015 Type D Description 0.15/share@7.50% Record Date 07-Nov-2025 Ratio 7.50

Ex-Date 04-Aug-2014 Type D Description 0.15/share@7.50% Record Date 07-Nov-2025 Ratio 7.50

Ex-Date 27-Sep-2013 Type B Description share@1:1 Record Date 30-Sep-2013 Ratio 1:1

Ex-Date 26-Aug-2013 Type D Description 0.20/share@10.00% Record Date 07-Nov-2025 Ratio 10.00

Ex-Date 21-Jul-2010 Type D Description 0.50/share@25.00% Record Date 07-Nov-2025 Ratio 25.00

Ex-Date 17-Jul-2009 Type D Description 0.40/share@20.00% Record Date 07-Nov-2025 Ratio 20.00

Ex-Date 17-Jul-2008 Type D Description 1.50/share@75.00% Record Date 07-Nov-2025 Ratio 75.00

Ex-Date 13-Aug-2007 Type D Description 1.00/share@50.00% Record Date 07-Nov-2025 Ratio 50.00

Dividends

Announcement Date 05-Aug-2025 Ex Dividend Date 05-Aug-2025 Dividend(%) 120

Announcement Date 05-Aug-2024 Ex Dividend Date 05-Aug-2024 Dividend(%) 120

Announcement Date 03-Aug-2023 Ex Dividend Date 03-Aug-2023 Dividend(%) 110

Announcement Date 12-Sep-2022 Ex Dividend Date 12-Sep-2022 Dividend(%) 90

Announcement Date 29-Jul-2021 Ex Dividend Date 29-Jul-2021 Dividend(%) 10

Announcement Date 29-Jul-2020 Ex Dividend Date 29-Jul-2020 Dividend(%) 30

Announcement Date 18-Sep-2019 Ex Dividend Date 18-Sep-2019 Dividend(%) 10

Announcement Date 27-Jul-2018 Ex Dividend Date 27-Jul-2018 Dividend(%) 10

Announcement Date 19-Jul-2017 Ex Dividend Date 19-Jul-2017 Dividend(%) 10

Announcement Date 01-Aug-2016 Ex Dividend Date 01-Aug-2016 Dividend(%) 8

Announcement Date 03-Aug-2015 Ex Dividend Date 03-Aug-2015 Dividend(%) 8

Announcement Date 04-Aug-2014 Ex Dividend Date 04-Aug-2014 Dividend(%) 8

Announcement Date 26-Aug-2013 Ex Dividend Date 26-Aug-2013 Dividend(%) 10

Announcement Date 21-Jul-2010 Ex Dividend Date 21-Jul-2010 Dividend(%) 25

Announcement Date 17-Jul-2009 Ex Dividend Date 17-Jul-2009 Dividend(%) 20

Announcement Date 17-Jul-2008 Ex Dividend Date 17-Jul-2008 Dividend(%) 75

Announcement Date 13-Aug-2007 Ex Dividend Date 13-Aug-2007 Dividend(%) 50

Bonus

Record Date 30-Sep-2013 Ex-Bonus Date 27-Sep-2013 Ratio 1:1

Splits

No Split has been declared by ALEMBICLTD

Others

Ex-Rights Date 22-Mar-2018 Premium(Rs.) Ratio

Alembic Ltd Peer Comparison

Shows key financial metrics for the company and its peers

This section compares Alembic Ltd with leading peers in the banking sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Alembic Ltd's relative performance and valuation against major competitors.

Stock Name IOL Chemicals & Pharmaceuticals Ltd ₹90.66 (+0.08%) M. Cap (Cr) 26.61 1 Yr Return (%) +10.52% P/E (TTM) 25.34 PB Ratio 1.60

Stock Name Morepen Laboratories Ltd ₹46.97 (-1.05%) M. Cap (Cr) 25.74 1 Yr Return (%) -45.34% P/E (TTM) 27.79 PB Ratio 2.23

Stock Name SMS Pharmaceuticals Ltd ₹289.25 (+1.62%) M. Cap (Cr) 27.09 1 Yr Return (%) -7.45% P/E (TTM) 35.06 PB Ratio 4.55

Stock Name Alembic Ltd ₹99.61 (-0.18%) M. Cap (Cr) 25.58 1 Yr Return (%) -27.10% P/E (TTM) 8.08 PB Ratio 1.09

Stock Name Solara Active Pharma Sciences Ltd ₹565.05 (+0.42%) M. Cap (Cr) 20.43 1 Yr Return (%) -30.70% P/E (TTM) 392.16 PB Ratio 2.30

Stock Name Indoco Remedies Ltd ₹260.95 (-1.32%) M. Cap (Cr) 24.07 1 Yr Return (%) -17.03% P/E (TTM) -21.78 PB Ratio 2.21

Stock Name Novartis India Ltd ₹672.25 (-2.48%) M. Cap (Cr) 16.60 1 Yr Return (%) -1.49% P/E (TTM) 19.26 PB Ratio 2.81

Alembic Ltd Cash Flow

Cash flow data provides a view of how money is generated and spent by Alembic Ltd, across its operating activities, investing activities, and financing activities.

PARTICULARS Operating Activities Mar 2025 81.03 Mar 2024 25.33 Mar 2023 34.70 Mar 2022 -21.87 Mar 2021 -212.58

PARTICULARS Investing Activities Mar 2025 -21.79 Mar 2024 22.60 Mar 2023 11.29 Mar 2022 22.66 Mar 2021 196.20

PARTICULARS Financing Activities Mar 2025 -57.70 Mar 2024 -47.77 Mar 2023 -46.08 Mar 2022 -5.66 Mar 2021 -35.01

PARTICULARS Net Cash Flow Mar 2025 1.54 Mar 2024 0.16 Mar 2023 -0.09 Mar 2022 -4.86 Mar 2021 -51.40

Alembic Ltd Shareholding Pattern

This shows the ownership breakdown of Alembic Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.

Promoter 70.88%

Public 27.68%

Other Institutions 0.05%

FII 1.38%

Mutual Funds null%

About Alembic Ltd

Alembic Limited is one of the India's most experienced manufactures of bulk drugs and pharmaceuticals formulation in human and animal healthcare. The Company operates primarily in the manufacture of Bulk Drugs and Real Estate Business. The company manufacture pharmaceuticals and chemicals, bulk drugs (penicillin and other antibiotics) and formulations. It works manufacturing facilities at Vadodara in Gujarat and Solan in Himachal Pradesh.Alembic Limited was incorporated in year 1907 with the name 'Alembic Chemical Works Company Limited' in Vadodara to manufacture tinctures and alcohol. The name of the Company was changed to 'Alembic Limited' in August, 1999. The Company started to manufacture cough syrup, vitamins, tonics and sulphur durgs in 1940. In 1961, it inaugurated the 'Pencillin Palnt'. In 1968, it started to manufacture Streptomycin.In the 1971, they manufactured Erythromycin using expertise from Eli Lilly, USA and in the year 1972, they launched Althrocin, a brand of Erythromycin. In year 1997, Althrocin become top selling brand in India. In the year 2001, they started to manufacture Cephalosporin C. In June 2001, the company formed a wholly owned subsidiary company named Alembic Europe Pvt Ltd in UK.In the year 2005, the company has launched ZERO, a new generation, no calories, Sucralose Based Sugar Substitute which gave entry for the company into the high-growth lifestyle OTC product segment. In May 2005, the generic alliances and API division were merged to form an independent SBU.The company has set up a formulation manufacturing facility at Baddi in Himachal Pradesh with a production capacity 900 million tablets and 600 million liquid oral bottles annually. During the year 2005-06, the company has increased the installed capacity of Tablets & Capsules and Oral Preparation & Ointments by 595 Million Nos and 720 MT respectively.During the year 2005-06, the company acquired API Plant at Karakhadi in Vadodara. In the year 2007, the company acquired the Non-Oncology Business of Dabur Pharma Ltd. Also in the same year, they entered into a licensing agreement for its Novel Drug Delivery Platform for Keppra XR with UCB Belgium. During the year 2007-08, the company acquired the API manufacturing facility of Nirayu Pvt Ltd at Panelav near Vododara.The Company formed a wholly owned subsidiary viz. Alembic Global Holding SA in Neuchatel, Switzerland in 2009. The Pharmaceutical Undertaking of the Company demerged and the same got transferred to Alembic Pharmaceuticals Limited with effect from Appointed date i.e. 1st April, 2010. The maiden real estate project -Samsara was completed in 2014. The Company launched second real estate project, VEDA in 2015-16. It further launched two API's in 2017. During year 2017-18, Alembic City Limited (formerly known as Alembic Exports Limited) became wholly-owned subsidiary of the Company.During 2018-19, the Composite Scheme of Arrangement comprising of transfer and vesting of the Identified Real Estate Undertaking of Alembic Limited (the Company / the First Demerged Company) into Shreno Limited (the First Transferee Company/ the Second Demerged Company) and transfer and vesting of Engineering Division and Investment Division of Shreno Limited into Nirayu Private Limited (the Second Transferee Company) and their respective shareholders with effect from the Appointed Date i.e. 1st November, 2018 was sanctioned by the Hon'ble National Company Law Tribunal, Ahmedabad Bench (`NCLT') vide its order dated 26th July, 2019. Accordingly, Scheme was made effective from 26th July, 2019.The Company launched a residential project VEDA - II during 2020. In FY 2025, VEDA-II, one of the Company's gated community project has been completed in FY 2025. The Company's upscale premium residential projects, Townhouse24 also achieved 100% sales during the year. Other premium projects like The Villas and The Gardens witnessed decent demand. The Company also launched another housing project with 3BHK and 4BHK configurations called The Park Crescent.

Chairman (Non-Executive)

Chirayu R Amin

Registered office Alembic Road, null, Vadodara, Gujarat, 390003

FAX :91-0265-2280550

Background

Incorporation Year 1907

Face Value ₹2.00

Market Lot 1

Alembic Ltd Latest News

VIEW MORE NEWS

FAQs on Alembic Ltd